Drug Testing Equipment Market Analysis

Sample (Blood, Urine, Oral Fluids, Breath, Hair)

The urine segment in the drug testing equipment market is expected to garner the largest revenue share of 35% by the year 2036 due to the growing use and trade of illegal and banned drugs such as opioids. Urine drug tests are majorly used to detect the positivity of substance abuse which is a cost-effective and non-invasive method that aids in the rapid detection of drug intake.

Moreover, the hair segment is further foreseen to witness to bring in notable revenue owing to its rapid adoption as is the least invasive method and this testing provides an extended detection window of about 90 days.

End User (Personal Users, Hospitals, Workplace & Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, and Pain Management Centers)

Drug testing equipment market from the workplace & school segment will hold a significant growth rate in the upcoming years. With the changing organizational policies and the growing percentage of jobs requiring background verification for accessing workplace employment eligibility, the adoption of pre-employment drug tests is increasing. This will lead the segment to rise.

Our in-depth analysis of the global market includes the following segments:

Product	Consumables Urine Testing Kits Rapid Test Devices Breathalyzer Chromatography
Sample	Blood Urine Oral Fluids Breath Hair
End User	Personal Users Hospitals Workplace & Schools Criminal Justice Systems and Law Enforcement Agencies Drug Testing Laboratories Drug Treatment Centers Pain Management Centers

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of drug testing equipment is estimated at USD 7.36 Billion.

The drug testing equipment market size was over USD 6.68 Billion in 2023 and is anticipated to cross USD 26.86 Billion by the end of 2036, witnessing more than 11.3% CAGR during the forecast period i.e., between 2024-2036. The rising use of intoxicants and controlled substances and the rising misuse of prescribed medicines are the major factors driving the market growth.

North America industry is poised to hold 40% of the revenue share by 2036, driven by existence of giant players in the industry encouraging drug screening in the region.

Sandoz International GmbH, Quest Diagnostics Incorporated, Butterfly Network, Inc., F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., GE Healthcare

Drug Testing Equipment Market Analysis